In support of improving patient care, TRC Healthcare/NetCE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit(s) for learning and change. NetCE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. NetCE designates this continuing education activity for 0.5 ANCC contact hour(s). NetCE designates this continuing education activity for 0.5 pharmacotherapeutic/pharmacology contact hour(s). NetCE designates this continuing education activity for 0.6 hours for Alabama nurses. NetCE designates this activity for 0.5 ACPE credit(s). ACPE Universal Activity Number: JA4008164-0000-25-624-H01-P. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Completion of this course constitutes permission to share the completion data with ACCME. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program. AACN Synergy CERP Category A.

In addition to states that accept ANCC, NetCE is approved as a provider of continuing education in nursing by: Alabama, Provider #ABNP0353 (valid through July 29, 2025); Arkansas, Provider #50-2405; California, BRN Provider #CEP9784; California, LVN Provider #V10662; California, PT Provider #V10842; District of Columbia, Provider #50-2405; Florida, Provider #50-2405; Georgia, Provider #50-2405; Kentucky, Provider #7-0054 through 12/31/2025; South Carolina, Provider #50-2405; West Virginia RN and APRN, Provider #50-2405.

This activity is designed to comply with the requirements of California Assembly Bill 1195, Cultural and Linguistic Competency.

Upon completion of this course, you should be able to:

1. Identify emerging trends in drug therapy and their place in patient care practices
2. List diabetes medications with cardiovascular benefit by reducing major adverse cardiovascular events (MACE) or heart failure hospitalizations.
3. Discuss considerations for safe use of SGLT2 inhibitors and GLP-1 agonists.

Stephen Carek, MD, CAQSM, DipABLM,

Lauren G. Pamulapati, PharmD, BCACP, Associate Professor, Ambulatory Care, Virginia Commonwealth University School of Pharmacy, and Clinical Pharmacist, Hayes Willis Health Center/VCU Health

Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, Professor, Pharmacy Practice Director, PGY2 Ambulatory Care Residency Program at Midwestern University College of Pharmacy, Downers Grove Campus, and Clinical Pharmacist at Northwestern Medicine

Contributing faculty, Stephen Carek, MD, CAQSM, DipABLM, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.

Contributing faculty, Lauren G. Pamulapati, PharmD, BCACP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.

Contributing faculty, Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.

Flora Harp, PharmD

The division planner has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.

Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.